logo

For the Inventor, By the Inventor

Castro Valley, CA, United States of America

Peter Tachi Callas

This inventor holds 27 USPTO granted patents and 10 published patent applications and 2 EPO patents, primarily in Cardiac Ablation Technology. Top assignees: Angiodynamics, Inc., Maquet Cardiovascular LLC, Virginia Tech Intellectual Properties Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Tachi Callas. Retrieved from https://idiyas.com/inventor/peter-tachi-callas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 27 

% Patents Active = 92.6

 

Average Co-Inventor Count = 3.9

ph-index = 13

Forward Citations = 1,026(Granted Patents)


Location History:

  • Redwood City, CA (US) (2009)
  • Castro Valley, CA (US) (2013 - 2024)

Company Filing History:

goldMedal17 out of 277 
 
Angiodynamics, Inc.
 patents
silverMedal7 out of 134 
 
Maquet Cardiovascular LLC
 patents
bronzeMedal2 out of 825 
 
Virginia Tech Intellectual Properties Inc.
 patents
4. 1 out of 4,116 
 
Cardiac Pacemakers, Inc.
 patents
5. 1 out of 19 
 
Foundry Innovation & Research 1, Ltd.
 patents
6. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Cardiac Rhythm
Electroporation
COPD
Electrical Ablation
Implantable Sensors
Epicardial Clip
Minimally-Invasive Procedures
Vascular Monitoring
Irreversible Electroporation
Target Zone
Energy Delivery
Vessel Harvesting
27 patents (USPTO):Explore Patents
1. 12564722 - System and method for synchronizing energy delivery to the cardiac rhythm (2026-03-03),
2. 12232792 - Device and method for electroporation based treatment (2025-02-25),
3. 12201349 - Congestive obstruction pulmonary disease (COPD) (2025-01-21),
4. 12102376 - System and method for increasing a target zone for electrical ablation (2024-10-01),
5. 11931096 - System and method for electrically ablating tissue of a patient (2024-03-19),
6. 11779238 - Implantable sensors for vascular monitoring (2023-10-10),
7. 11707629 - System and method for synchronizing energy delivery to the cardiac rhythm (2023-07-25),
8. 11311381 - Epicardial clip (2022-04-26),
9. 11033324 - System and method for electrically ablating tissue of a patient (2021-06-15),
10. 10813688 - Congestive obstruction pulmonary disease (COPD) (2020-10-27),
11. 10702326 - Device and method for electroporation based treatment of stenosis of a tubular body part (2020-07-07),
12. 10485663 - Epicardial clip (2019-11-26),
13. 10342600 - System and method for increasing a target zone for electrical ablation (2019-07-09),
14. 10154876 - System and method for electrically ablating tissue of a patient (2018-12-18),
15. 10130819 - System and method for synchronizing energy delivery to the cardiac rhythm (2018-11-20),

Title: The Inventor Profile of Peter Tachi Callas

Introduction: Peter Tachi Callas, a male inventor hailing from Castro Valley, CA (US), is known for his innovative contributions in various fields.

Latest Patents: Peter Tachi Callas holds several patents in the areas of technology and engineering, showcasing his dedication to advancing these industries.

Career Highlights: Throughout his career, Peter Tachi Callas has demonstrated a keen ability to develop groundbreaking solutions to complex problems, earning him recognition as a leading inventor in his field.

Collaborations: Peter Tachi Callas has collaborated with top research institutions and companies to bring his inventions to life, further solidifying his reputation as a prolific inventor.

Conclusion: Peter Tachi Callas continues to inspire with his inventive spirit and commitment to pushing the boundaries of what is possible in the world of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…